Skip to content


We facilitate the discovery, refinement and adoption of precision biomarkers into treatment stratification for cancer, inflammatory disorders and mitochondrial disease and make pivotal contributions to strategic projects including the MRC Biobanking partnership awards in Pancreatic and Immune-mediated Inflammatory Diseases and major Innovate UK and NIHR awards.


We continue to build on our close links with the NIHR Newcastle MedTech and in vitro Diagnostic Cooperative (MIC), industrial partners including diagnostic, pharmaceutical companies, SMEs, Newcastle University research groups including bioengineering, data sciences, medicine, clinical trials and the NIHR Observatory, working as part of a single translational research organisation – Diagnostics North East (DxNE).


Since officially opening in December 2016, the Proximity Lab has successfully delivered 83 individual projects with a further 20 projects currently in progress. NovoPath has been instrumental to a number of successful grant and project applications now totalling £22M.